NCT00835705View on ClinicalTrials.gov

Amoxicillin-Clavulanic Acid 400 Mg-57 mg Chewable Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

September 30, 2003

Study Completion Date

September 30, 2003

Conditions
Healthy
Interventions
DRUG

amoxicillin-clavulanic acid

400 mg-57 mg chewable tablet

DRUG

Augmentin®

400 mg-57 mg chewable tablet

Trial Locations (1)

G1V 2K8

Anapharm Inc., Sainte-Foy

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00835705 - Amoxicillin-Clavulanic Acid 400 Mg-57 mg Chewable Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter